Product NDC: | 0555-9013 |
Proprietary Name: | Lessina |
Non Proprietary Name: | levonorgestrel and ethinyl estradiol |
Active Ingredient(s): | .02; .1 mg/1; mg/1 & nbsp; levonorgestrel and ethinyl estradiol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-9013 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075803 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020422 |
Package NDC: | 0555-9013-57 |
Package Description: | 6 POUCH in 1 CARTON (0555-9013-57) > 1 BLISTER PACK in 1 POUCH > 21 TABLET in 1 BLISTER PACK |
NDC Code | 0555-9013-57 |
Proprietary Name | Lessina |
Package Description | 6 POUCH in 1 CARTON (0555-9013-57) > 1 BLISTER PACK in 1 POUCH > 21 TABLET in 1 BLISTER PACK |
Product NDC | 0555-9013 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levonorgestrel and ethinyl estradiol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20020422 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | ETHINYL ESTRADIOL; LEVONORGESTREL |
Strength Number | .02; .1 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |